These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8843225)
21. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial. Treanor JJ; El Sahly H; King J; Graham I; Izikson R; Kohberger R; Patriarca P; Cox M Vaccine; 2011 Oct; 29(44):7733-9. PubMed ID: 21835220 [TBL] [Abstract][Full Text] [Related]
22. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice. Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133 [TBL] [Abstract][Full Text] [Related]
24. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Leroux-Roels I; Vets E; Freese R; Seiberling M; Weber F; Salamand C; Leroux-Roels G Vaccine; 2008 Dec; 26(51):6614-9. PubMed ID: 18930093 [TBL] [Abstract][Full Text] [Related]
25. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
26. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens. Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655 [TBL] [Abstract][Full Text] [Related]
27. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Tang XC; Lu HR; Ross TM Vaccine; 2010 Oct; 28(42):6821-31. PubMed ID: 20727393 [TBL] [Abstract][Full Text] [Related]
28. Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial. Treanor JJ; Chu L; Essink B; Muse D; El Sahly HM; Izikson R; Goldenthal KL; Patriarca P; Dunkle LM Vaccine; 2017 Feb; 35(6):923-928. PubMed ID: 28089141 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system. Na HN; Kim KH; Song MK; Park HL; Lee EY; Shim SH; Park S; Nam JH Microbiol Immunol; 2013 Sep; 57(9):660-4. PubMed ID: 23822120 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000 [TBL] [Abstract][Full Text] [Related]
31. Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs. Hernandez LA; Miller CL; Vaughn EM Vet Microbiol; 2016 Aug; 191():35-43. PubMed ID: 27374905 [TBL] [Abstract][Full Text] [Related]
32. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262 [TBL] [Abstract][Full Text] [Related]
33. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795 [TBL] [Abstract][Full Text] [Related]
34. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge. Prabakaran M; Kolpe AB; He F; Kwang J Vaccine; 2013 Feb; 31(10):1385-92. PubMed ID: 23328313 [TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Pépin S; Donazzolo Y; Jambrecina A; Salamand C; Saville M Vaccine; 2013 Nov; 31(47):5572-8. PubMed ID: 24016810 [TBL] [Abstract][Full Text] [Related]
36. Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Nolan TM; Richmond PC; Skeljo MV; Pearce G; Hartel G; Formica NT; Höschler K; Bennet J; Ryan D; Papanaoum K; Basser RL; Zambon MC Vaccine; 2008 Aug; 26(33):4160-7. PubMed ID: 18599164 [TBL] [Abstract][Full Text] [Related]
37. Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age. Dunkle LM; Izikson R; Patriarca PA; Goldenthal KL; Muse D; Cox MMJ J Infect Dis; 2017 Dec; 216(10):1219-1226. PubMed ID: 28968871 [TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Greenberg DP; Robertson CA; Noss MJ; Blatter MM; Biedenbender R; Decker MD Vaccine; 2013 Jan; 31(5):770-6. PubMed ID: 23228813 [TBL] [Abstract][Full Text] [Related]
39. A fast track influenza virus vaccine produced in insect cells. Cox MM; Hashimoto Y J Invertebr Pathol; 2011 Jul; 107 Suppl():S31-41. PubMed ID: 21784229 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age. Rodriguez Weber MA; Claeys C; Aranza Doniz C; Feng Y; Innis BL; Jain VK; Peeters M Pediatr Infect Dis J; 2014 Dec; 33(12):1262-9. PubMed ID: 25386965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]